We studied prophylactic antibiotics administered at 2 academic medical centers during a 6-year period where a cephalosporin was indicated but an "allergy" to penicillin was noted. Another drug (typically vancomycin or clindamycin) was substituted approximately 80% of the time; this occurred frequently even when symptoms unrelated to acute hypersensitivity were listed. In >50% of cases, the reaction was either omitted or vague (e.g., simply "rash"). Given the estimated 1% cross-reactivity between penicillins and cephalosporins with similar R1 side chains, many of these patients could have received either the prescribed cephalosporin or another cephalosporin with a different R1 side chain.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1213/XAA.0000000000000253 | DOI Listing |
Int Urogynecol J
January 2025
Westmead Hospital, Pelvic Floor Unit, Wentworthville, PO Box 533, Sydney, NSW, 2145, Australia.
Background: Group B streptococcus (GBS) causes neonatal invasive disease, mainly sepsis and meningitis. Understanding the clinical characteristics, laboratory tests, and antibiotic resistance patterns of GBS invasive infections provides reliable epidemiological data for preventing and treating GBS infections.
Methods: Clinical characteristics and laboratory test results from 86 patients with neonatal invasive disease (45 cases of early-onset disease [EOD] and 41 cases of late-onset disease [LOD]) recruited from Fujian Maternity and Child Health Hospital between January 2012 and December 2021 were analyzed.
PLoS One
January 2025
Department of Midwifery, Faculty of Nursing and Midwifery, Lira University, Lira, Uganda.
Background: Sepsis is one of the leading causes of mortality and morbidity among neonates. An estimated 5.29-8.
View Article and Find Full Text PDFGlobal Spine J
January 2025
Department of Neurosurgery, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Study Design: Narrative Review.
Objective: Contextualized by a narrative review of recent literature, we propose a wound complication prevention and management algorithm for spinal oncology patients. We highlight available strategies and motivate future research to identify optimal and individualized wound management for this population.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!